446 related articles for article (PubMed ID: 15930343)
1. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
3. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
Park D; Kåresen R; Axcrona U; Noren T; Sauer T
APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
McCarthy MM; Sznol M; DiVito KA; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jul; 11(14):5188-94. PubMed ID: 16033835
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Kowalski PJ; Rubin MA; Kleer CG
Breast Cancer Res; 2003; 5(6):R217-22. PubMed ID: 14580257
[TBL] [Abstract][Full Text] [Related]
9. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Invasion Metastasis; 1996; 16(1):19-26. PubMed ID: 8830762
[TBL] [Abstract][Full Text] [Related]
11. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
[TBL] [Abstract][Full Text] [Related]
12. Cadherins as predictive markers of nodal metastasis in breast cancer.
Madhavan M; Srinivas P; Abraham E; Ahmed I; Mathew A; Vijayalekshmi NR; Balaram P
Mod Pathol; 2001 May; 14(5):423-7. PubMed ID: 11353052
[TBL] [Abstract][Full Text] [Related]
13. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
Arnes JB; Brunet JS; Stefansson I; Bégin LR; Wong N; Chappuis PO; Akslen LA; Foulkes WD
Clin Cancer Res; 2005 Jun; 11(11):4003-11. PubMed ID: 15930334
[TBL] [Abstract][Full Text] [Related]
14. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.
Nagi C; Guttman M; Jaffer S; Qiao R; Keren R; Triana A; Li M; Godbold J; Bleiweiss IJ; Hazan RB
Breast Cancer Res Treat; 2005 Dec; 94(3):225-35. PubMed ID: 16258702
[TBL] [Abstract][Full Text] [Related]
15. High HSP90 expression is associated with decreased survival in breast cancer.
Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
17. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.
Gamallo C; Moreno-Bueno G; Sarrió D; Calero F; Hardisson D; Palacios J
Mod Pathol; 2001 Jul; 14(7):650-4. PubMed ID: 11454996
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma].
Wang LH; Liu DY; Chen YJ; Hou L; Wang B; Mao LM; Lu S
Ai Zheng; 2002 Sep; 21(9):965-9. PubMed ID: 12508543
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in invasive breast cancer.
Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
